NAMS
NewAmsterdam Pharma Company N.V.
NASDAQ Healthcare
32,63 $US
+3.92% today
-7.30% YTD · +78.01% 1Y
7
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
15
Hedge funds tracked
200+ 13F SEC funds, updated quarterly
16
Thematic ETFs
ARK, NANC, GOP, GURU, BUZZ, JEPI, ITA…
24h
Frequency
Daily 5AM UTC pipeline · 2-year historical DB
65
/ 100
STRONG

Kairos Score: 65/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer’s disease. NewAmsterdam Pharma Company N.V. is headquartere...

Key info

🎂
Founded
2019
👥
Employees
100
💰
Market cap
3 814 576 835,00 $US

🕴️ Insider activity (90 days)

7 transactions — including 0 buys declared by NewAmsterdam Pharma Company N.V. executives to SEC / AMF / BaFin.

KL
Kooij Louise Frederika
Chief Accounting Officer · 2026-06-22
Other
KL
Kooij Louise Frederika
Chief Accounting Officer · 2026-06-22
Other
KL
Kooij Louise Frederika
Chief Accounting Officer · 2026-06-22
Other

🏦 Hedge Funds

15 institutional funds report a position on NAMS in their latest SEC quarterly filing.

Capital World Investors
FMR LLC
WELLINGTON MANAGEMENT GROUP LLP
VIKING GLOBAL INVESTORS LP
Polar Capital Holdings Plc

📰 Recent news

15 recent articles on NAMS.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Automatic detection when 3+ executives buy the same stock simultaneously — historically the most reliable signal.

🏦

13F Hedge Funds

Berkshire (Buffett), Pershing Square (Ackman), Tiger Global, Bridgewater + 200 more. Who buys what, each quarter.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot small caps whose retail interest explodes before the rest of the market. 100+ tickers monitored.

📧

Email alerts

Create your watchlist and receive every morning at 8am the Brief of events on YOUR tickers.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of NAMS on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 7 insider transactions over 90 days
✅ All 15 hedge funds (among 200+ tracked)
✅ 11 thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ 2-year history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + 6-quarter earnings
See full analysis →
Analyze other tickers for free →

Free signup · Premium €29/month no commitment